Skip to main content

Table 4 Intra-procedural and post angioplasty anticoagulants and anti-platelets used

From: Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis

StudiesIntra-procedural anti-platelets/anti-coagulantsPost procedural/discharge anti-platelets (majority)Duration of DAPT useAccess site for PCI
Ayoub 2018 [8]Not mentionedNot mentionedNot mentionedNot mentioned
Ito 2018 [9]Unfractionated heparinAspirin, clopidogrel or ticlopidine (DAPT)≥ 3 monthsNot mentioned
Kiviniemi 2013 [10]LMWH (enoxaparin sodium and dalteparin), unfractionated heparin, bivalirudin, and glycoprotein IIb/IIIa inhibitorsAspirin, clopidogrel and warfarin Or Aspirin and clopidogrel (DAPT)1–3 monthsFemoral access
Liu 2018 [11]Aspirin, clopidogrel, LMWH, glycoprotein IIb/IIIa inhibitorsAspirin and clopidogrel (DAPT)short term use without mentioning the exact time durationNot mentioned
Overgaard 2008 [12]Not mentionedNot mentionedNot mentionedFemoral access
Raphael 2016 [13]Aspirin, clopidogrel, heparinAspirin and clopidogrel (DAPT)Not mentionedFemoral > radial access
Shiraishi 2019 [14]Aspirin, thienopyridineAspirin, clopidogrel, ticlopidine or prasugrel (DAPT)Not mentionedRadial > femoral access
Yadav 2016 [15]Heparin, bivalirudin, and glycoprotein IIb/IIIa inhibitors, aspirin and clopidogrelAspirin, clopidogrel, ticlopidine or prasugrel (DAPT)Not mentionedNot mentioned
  1. Abbreviations: LMWH low molecular weight heparin, DAPT dual antiplatelet therapy, PCI percutaneous coronary intervention